Tag Archives: It’s

Bluebird CEO defends $1.8 million gene therapy price — ‘It’s really thinking about it differently’

Bluebird Bio CEO Nick Leschly on Friday defended the biotech company’s $ 1.8 million price tag for its new gene therapy to treat a rare genetic blood disorder. Bluebird’s therapy, Zynteglo, was approved in Europe earlier this month for patients with beta thalassemia who require regular blood transfusions to manage their disease and have no… Read More »

It’s easier to order a takeaway online than it is to book a fitness class

Booking a badminton court or pilates class should be as easy as ordering a takeaway, says Sports Minister as she bemoans obstacles that put people off exercising Sport England quizzed almost 2,000 adults living in England for the survey Two thirds of respondents said they found it easy to order a takeaway online  While only… Read More »